Tamayo, CA
Abigail F. Tamayo, Walnut, CA US
Patent application number | Description | Published |
---|---|---|
20140358263 | TRIGGERING CONTROL OF AUDIO FOR WALK-AROUND CHARACTERS - A control system for selectively operating a sound system provided in a walk-around character costume. e.g., to play audio files in an order defined by a dialog tree that can be navigated by a performer wearing the costume. The control system includes a trigger mechanism provided in the costume operable by a performer wearing the costume to generate and transmit at least one trigger signal to navigate through a dialog tree. A controller receives the trigger signal and transmits a control signal causing the sound system to playback pre-recorded dialog. The system includes a trigger processing module run by the controller for processing the trigger signal and, in response to such processing, for navigating pre-recorded audio for a show to select the set of pre-recorded dialog. The trigger mechanism includes a first and a second pressure sensor in a thumb and index finger of a glove of the costume. | 12-04-2014 |
Arnold Tamayo, Glendale, CA US
Patent application number | Description | Published |
---|---|---|
20090140640 | LUMINESCENT COMPOUNDS WITH CARBENE LIGANDS - An organic light emitting device is provided. The device has an anode, a cathode and an organic layer disposed between the anode and the cathode. The organic layer comprises a compound further comprising one or more carbene ligands coordinated to a metal center. | 06-04-2009 |
20090302754 | CARBENE CONTAINING METAL COMPLEXES AS OLEDS - A process for preparing a compound having the formula L | 12-10-2009 |
20100013386 | NEAR INFRARED EMITTING ORGANIC COMPOUNDS AND ORGANIC DEVICES USING THE SAME - Certain iridium compounds which may comprise an iridium(III)-ligand complex having the general formula: (ĈN) | 01-21-2010 |
20120025698 | PHENYL AND FLUORENYL SUBSTITUTED PHENYL-PYRAZOLE COMPLEXES OF Ir - The invention provides emissive materials and organic light emitting devices using the emissive materials in an emissive layer disposed between and electrically connected to an anode and a cathode. The emissive materials include compounds with the following structure: | 02-02-2012 |
20130119361 | PHENYL AND FLUORENYL SUBSTITUTED PHENYL-PYRAZOLE COMPLEXES OF Ir - The invention provides emissive materials and organic light emitting devices using the emissive materials in an emissive layer disposed between and electrically connected to an anode and a cathode. The emissive materials include compounds with the following structure: | 05-16-2013 |
20140332783 | Phenyl and Fluorenyl Substituted Phenyl-Pyrazole Complexes of lr - The invention provides emissive materials and organic light emitting devices using the emissive materials in an emissive layer disposed between and electrically connected to an anode and a cathode. The emissive materials include compounds with the following structure: | 11-13-2014 |
Arnold B. Tamayo, Santa Barbara, CA US
Patent application number | Description | Published |
---|---|---|
20150034161 | ORGANIC SEMICONDUCTING COMPOUNDS FOR USE IN ORGANIC ELECTRONIC DEVICES - Organic molecule semi-conducting chromophores containing a halogen-substituted core structure are disclosed. Such compounds can be used in organic heterojunction devices, such as organic molecule solar cells and transistors. | 02-05-2015 |
Juan Tamayo, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20140279824 | TIME-SENSITIVE CUBE - A time-sensitive cube data system is disclosed in which time-sensitive and/or time-series data objects are output in response to a user's operations on a time-sensitive OLAP cube. The time-sensitive and/or time-series data objects output by the time-sensitive cube data system may be displayed to the user in any way that may be advantageous to the user's understanding. The time-series objects output by the time-sensitive cube data system are more helpful than a single snapshot, as a user is able to see data trends over time. | 09-18-2014 |
20150039554 | TIME-SENSITIVE CUBE - A time-sensitive cube data system is disclosed in which time-sensitive and/or time-series data objects are output in response to a user's operations on a time-sensitive OLAP cube. The time-sensitive and/or time-series data objects output by the time-sensitive cube data system may be displayed to the user in any way that may be advantageous to the user's understanding. The time-series objects output by the time-sensitive cube data system are more helpful than a single snapshot, as a user is able to see data trends over time. | 02-05-2015 |
Nuria Tamayo, Newbury Park, CA US
Patent application number | Description | Published |
---|---|---|
20090082358 | Vanilloid receptor ligands and their use in treatments - Bicyclic 3,4-fused piperidine compounds, and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotizing agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders. | 03-26-2009 |
20100261728 | TRP-M8 RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS - Tetrahydroisoquinoline compounds of formula (I), and compositions containing them, for the treatment of acute, inflammatory and neurophatic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neurophatic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders. | 10-14-2010 |
Nuria A. Tamayo, Newbury Park, CA US
Patent application number | Description | Published |
---|---|---|
20090054405 | PI3 kinase modulators and methods of use - The present invention comprises a new class of compounds capable of modulating the activity of PI3 kinase and, accordingly, useful for treatment of PI3 kinase mediated diseases, including melanomas, carcinomas and other cancer-related conditions. The compounds have a general Formula I | 02-26-2009 |
20090163489 | Inhibitors of PI3 kinase - The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt thereof, that inhibit phosphoinositide 3-kinase; | 06-25-2009 |
20100273764 | INHIBITORS OF PI3 KINASE AND/OR MTOR - The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt thereof; | 10-28-2010 |
20110092504 | INHIBITORS OF PI3 KINASE - The present invention relates to compounds of Formula (I), or a pharmaceutically acceptable salt thereof; methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds, wherein Q, X | 04-21-2011 |
20120071474 | INHIBITORS OF PI3 KINASE - The present invention relates to compounds of Formula I, II or III or a pharmaceutically acceptable salt thereof; | 03-22-2012 |
20120225854 | COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES - The present invention relates to compounds of Formula I, or pharmaceutically acceptable salts thereof, | 09-06-2012 |
20130079303 | Inhibitors of PI3 Kinase and/or mTOR - The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt thereof; | 03-28-2013 |
20140213581 | FUSED MULTI-CYCLIC SULFONE COMPOUNDS AS INHIBITORS OF BETA-SECRETASE AND METHODS OF USE THEREOF - The present invention provides a new class of compounds useful for the modulation of beta-secretase enzyme (BACE) activity. The compounds have a general Formula I: | 07-31-2014 |
20140249104 | PERFLUORINATED 5,6-DIHYDRO-4H-1,3-OXAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE - The present invention provides a new class of compounds useful for the modulation of beta-secretase enzyme (BACE) activity. The compounds have a general Formula I: | 09-04-2014 |